Literature DB >> 15647684

Cesium attenuation correction of the liver dome revealing hepatic lesion missed with computed tomography attenuation correction because of the respiratory motion artifact.

Dimitri Papathanassiou1, Jean-Claude Liehn, Benoît Bourgeot, Roland Amir, Claude Marcus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15647684     DOI： 10.1097/00003072-200502000-00015

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


× No keyword cloud information.
  5 in total

1.  Respiratory-induced errors in tumor quantification and delineation in CT attenuation-corrected PET images: effects of tumor size, tumor location, and respiratory trace: a simulation study using the 4D XCAT phantom.

Authors:  Parham Geramifar; Mojtaba Shamsaie Zafarghandi; Pardis Ghafarian; Arman Rahmim; Mohammad Reza Ay
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

2.  Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source.

Authors:  Dimitri Papathanassiou; Stéphanie Becker; Roland Amir; Benoît Menéroux; Jean-Claude Liehn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-31       Impact factor: 9.236

Review 3.  Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in oncology: a systematic review.

Authors:  Urvi Joshi; Pieter G H M Raijmakers; Ingrid I Riphagen; Gerrit J J Teule; Arthur van Lingen; Otto S Hoekstra
Journal:  Mol Imaging Biol       Date:  2007 May-Jun       Impact factor: 3.488

4.  Breath-hold and free-breathing F-18-FDG-PET/CT in malignant melanoma-detection of additional tumoral foci and effects on quantitative parameters.

Authors:  Robert Bärwolf; Mariana Zirnsak; Martin Freesmeyer
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

5.  Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to 18F-FDG-PET/CT.

Authors:  Donatienne Van Weehaeghe; Olivier Gheysens; Vincent Vandecaveye; Patrick Schöffski; Koen Van Laere; Christophe M Deroose
Journal:  BMC Cancer       Date:  2018-03-05       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.